Total Voting Rights

RNS Number : 6212W
Zoetic International PLC
30 April 2021
 

 

30 April 2021

 

Zoetic International plc

('Zoetic', the 'Company' or the 'Group')

 

Total Voting Rights

 

Zoetic International plc (LSE: ZOE), the international CBD group , announces that the issued share capital of the Company at the date of this announcement comprises 202,070,034 ordinary shares of 1 pence each with one voting right per share ('Ordinary Shares').  The Company does not hold any Ordinary Shares in treasury. The total number of Ordinary Shares and voting rights in the Company is therefore  202,070,034.

 

This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

Publication on website

 

A copy of this announcement is also available on the Group's website at       www.zoeticinternational.com

 

Media enquiries:

Zoetic International plc

c/o Buchanan

Trevor Taylor, Co-CEO

Antonio Russo, Co-CEO

 


Allenby Capital Limited (Financial Adviser and Broker)

+44 (0) 20 3328 5656

Nick Harriss (Corporate Finance)


Nick Naylor (Corporate Finance)


Guy McDougall (Equity Sales)

 


 

Buchanan


Henry Harrison-Topham / Jamie Hooper / Ariadna Peretz

Tel: +44 (0) 20 7466 5000

zoetic@buchanan.uk.com

www.buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREADLKAFFFEFA
UK 100

Latest directors dealings